1. Almost a million people have been given an experimental Chinese coronavirus vaccine  msnNOW
  2. Almost a million people have been given an experimental Chinese coronavirus vaccine, pharmaceutical giant claims  CNN
  3. Kaiser Permanente begins testing Pfizer COVID-19 vaccine candidate on adolescents  Sacramento Bee
  4. Teens are the youngest volunteers in COVID-19 vaccine trials  The Mercury News
  5. Oxford University trial vaccine 'highly effective' on adults  Sky News Australia
  6. View Full Coverage on Google News
Almost a million people have been given an experimental coronavirus vaccine developed by Sinopharm as part of an emergency-use program authorized by Beijing, the Chinese pharmaceutical giant's chairman said.

Almost a million people have been given an experimental Chinese coronavirus vaccine

Experts say the pandemic needs a global solution, but there are concerns over access to vaccines.Experts say the pandemic needs a global solution, but there are concerns over access to vaccines.

sign-in

Health Secretary Matt Hancock reveals the government has now taken the "first step" for authorising a vaccine in the UK.Health Secretary Matt Hancock reveals the government has now taken the "first step" for authorising a vaccine in the UK.

COVID-19 vaccine: Pfizer coronavirus jab to be rolled out next month if approved by UK regulator, govt announces | Politics News | Sky News

A government map showing the number of COVID-19 infections per capita on a county level for last week shows just how widespread COVID-19 has become across the United States.A government map showing the number of COVID-19 infections per capita on a county level for last week shows just how widespread COVID-19 has become across the United States.

COVID-19 US: Red wave map shows how widespread infection is | Daily Mail Online

During an interview on Friday morning, the health secretary said that coronavirus vaccines could be delivered alongside the flu jab within weeks During an interview on Friday morning, the health secretary said that coronavirus vaccines could be delivered alongside the flu jab within weeks

UK just 'weeks away' from mass Covid vaccine programme, says Matt Hancock - Chronicle Live

403 Missing Auth Token

With Pfizer, Moderna as well as developers of Sputnik V and CoronaVac citing over 90% efficacy of their vaccines, the world finally has a reason to hope 2021 will be different.With Pfizer, Moderna as well as developers of Sputnik V and CoronaVac citing over 90% efficacy of their vaccines, the world finally has a reason to hope 2021 will be different.

There's light at the end of the Covid tunnel — the glimmer of a vaccine needle

403 Forbidden

A member of my family who is not in a science or medical field recently asked for my thoughts on the new vaccines in development to combat COVID-19. She, like many Americans, voiced a fear at the prospect of taking a vaccine that felt “rushed.”A member of my family who is not in a science or medical field recently asked for my thoughts on the new vaccines in development to combat COVID-19. She, like many Americans, voiced a fear at the prospect of taking a vaccine that felt “rushed.”

Allison Weis: The COVID-19 vaccines might feel rushed, but they aren’t - The Salt Lake Tribune

All we really want for Christmas is a COVID vaccine.

EDITORIAL: A very merry shot in the arm | Toronto Sun

EDITORIAL: A very merry shot in the arm | Toronto Sun

Being one of the worst-hit countries with coronavirus cases still rising in huge numbers, India is curiously waiting for a promising announcement with approvals by regulatory authorities monitoring the progress of several vaccine candidates. India’s realistic hopes, however, hinge heavily on 3 to 5 vaccine candidates.Being one of the worst-hit countries with coronavirus cases still rising in huge numbers, India is curiously waiting for a promising announcement with approvals by regulatory authorities monitoring the progress of several vaccine candidates. India’s realistic hopes, however, hinge heavily on 3 to 5 vaccine candidates.

Pfizer to Covaxin: An account of Covid-19 vaccine candidates for India - News Analysis News

As coronavirus cases continue to rise across the country, White House officials say a coronavirus vaccine could be here by the holidays.As coronavirus cases continue to rise across the country, White House officials say a coronavirus vaccine could be here by the holidays.

Coronavirus vaccine could come ‘within weeks,’ White House says | WFLA

Florida added another 9,000 COVID-19 cases Friday, bringing the total to more than 914,000 in the state since the start of the pandemic.Florida added another 9,000 COVID-19 cases Friday, bringing the total to more than 914,000 in the state since the start of the pandemic.

Florida stands ready to receive COVID-19 vaccines

The Department of Health and Social Care has made over 50s a new vulnerable group that can get flu vaccines for free.The jabs are part of the Government's plan to protect vulnerable people from the double-threat of coronavirus and flu.

Free flu jabs for over-50s from the start of next month | Metro News

This is a watershed moment where all of us must recognise that no one’s health is fully protected until all of us areThis is a watershed moment where all of us must recognise that no one’s health is fully protected until all of us are

We are facing an unprecented global challenge to protect every country from Covid-19

Bloomberg - Are you a robot?

The Health Secretary has formally asked the medicines regulator to assess the Pfizer/BioNTech coronavirus vaccine for use in the UK.Matt Hancock hailed it as “another important stepThe Health Secretary has formally asked the medicines regulator to assess the Pfizer/BioNTech coronavirus vaccine for use in the UK.Matt Hancock hailed it as “another important step

Covid-19 vaccine: When will it be ready and how can I get it? - AOL

Britain has formally asked its medical regulator, the MHRA, to assess the Pfizer-BioNTech COVID-19 vaccine for its suitability, the first step in making the shot available outside of the United States.Britain has formally asked its medical regulator, the MHRA, to assess the Pfizer-BioNTech COVID-19 vaccine for its suitability, the first step in making the shot available outside of the United States.

Britain asks regulator to assess Pfizer vaccine for suitability | Reuters

Britain has formally asked its medical regulator, the MHRA, to assess the Pfizer-BioNTech COVID-19 vaccine for its suitability, the first step in making the shot available outside of the United States.Britain has formally asked its medical regulator, the MHRA, to assess the Pfizer-BioNTech COVID-19 vaccine for its suitability, the first step in making the shot available outside of the United States.

Britain asks regulator to assess Pfizer vaccine for suitability | Article [AMP] | Reuters

As the race to release a viable coronavirus vaccine hots up, a Chinese pharmaceutical company claims to have inoculated nearly a million people against COVID-19 with so far still experimental vaccines.As the race to release a viable coronavirus vaccine hots up, a Chinese pharmaceutical company claims to have inoculated nearly a million people against COVID-19 with so far still experimental vaccines.

Coronavirus: Nearly 1 million people already inoculated with two experimental Chinese vaccines | Euronews

The British government has requested that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) assess the Pfizer and BioNTech vaccine, as Health Secretary Matt Hancock hopes to roll it out from December.The British government has requested that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) assess the Pfizer and BioNTech vaccine, as Health Secretary Matt Hancock hopes to roll it out from December.

UK requests Pfizer & BioNTech jab assessment from regulator, hopes to start Covid vaccinations ‘next month’ — RT UK News

UK ‘heading in the right direction but there is still a long way to go’ UK ‘heading in the right direction but there is still a long way to go’ 

Covid vaccinations could be rolled out next month as ministers ask for regulator’s assessment | The Independent

GPs will not be required to deliver the majority of Covid-19 vaccinations that are administered this year, the health secretary has confirmed. In today’s Downing Street press briefing Matt Hancock said mass vaccination centres would deliver the bulk of the programme next month – and GPs would take a more prominent role in 2021. The

GPs will not deliver bulk of Covid-19 vaccines given this year, says Hancock - Pulse Today

Now, Sinovac Biotech's candidate vaccine, CoronaVac, has been found to induce an immune response in healthy adults aged 18–59 years, 28 days post-vaccination. However, the level of antibodies generated was lower than in people who had recovered from the illness.Now, Sinovac Biotech's candidate vaccine, CoronaVac, has been found to induce an immune response in healthy adults aged 18–59 years, 28 days post-vaccination. However, the level of antibodies generated was lower than in people who had recovered from the illness.

Sinovac Biotech's COVID-19 vaccine candidate triggers immune response

China's vaccines are gaining international momentum and a growing number of countries are lining up to purchase them.

Why China's vaccines are gaining international momentum - CGTN

The Government is hoping to start vaccinating against COVID-19 next month, with the bulk of the vaccination roll out in the New Year, Health Secretary Matt Hancock has announced this evening (Friday). The Pfizer BioNTech vaccine is now going through a rigorous analysis as a result of the Government formally asking the independent regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), to assess the vaccine with a view to authorising its use as soon as possible. Tonight's news is a massive breakthrough in the battle against COVID-19, with the Pfizer vaccine said to be 95% effective with no serious safety concerns. Other vaccines are also being created. Health Secretary Matt Hancock has said he is instructing the NHS to be ready to distribute the vaccine to population 'as fast as it can be produced', from as early as December. The vaccine will be available across the UK through the NHS, for free, and will be distributed based on need. Priority will be given to those at greatest risk. It's been confirmed that the vaccine will be delivered through vaccination centres, through vaccination hubs at hospitals and then, in the New Year, a community vaccination roll out through GPs and pharmacists. Furthermore, it has been announced tonight that free flu jabs will be made available for all over 50s from December.

COVID-19 VACCINE SET TO BE DISTRIBUTED FROM DECEMBER ANNOUNCES GOVERNMENT - Island Echo - 24hr news, 7 days a week across the Isle of Wight

Health Secretary Matt Hancock is hosting Friday night's Downing Street press briefing in a week where the Pfizer, Moderna and Oxford University Covid-19 vaccines have all made promising breakthroughsHealth Secretary Matt Hancock is hosting Friday night's Downing Street press briefing in a week where the Pfizer, Moderna and Oxford University Covid-19 vaccines have all made promising breakthroughs

Brits could start getting Pfizer Covid vaccine as soon as next month, No.10 confirms - Daily Star

Matt Hancock has confirmed the Pfizer-BioNTech Covid-19 vaccine will begin to be rolled out next month if it is approved for widespread use. Matt Hancock has confirmed the Pfizer-BioNTech Covid-19 vaccine will begin to be rolled out next month if it is approved for widespread use.

Vaccine hope: Covid jabs for all of UK by Spring - LBC

Here's what a pandemic expert thinks about the recent coronavirus vaccine trial data.Here's what a pandemic expert thinks about the recent coronavirus vaccine trial data.

A Doctor Explains: What Pfizer's Big Coronavirus Vaccine News Means | The Motley Fool

Pfizer and BioNTech have submitted their covid-19 vaccine candidate to the US Food and Drug Administration (FDA) for emergency use authorisation, after concluding a phase III trial. The mRNA vaccine candidate, BNT162b2, was found to be 95% effective 28 days after the first dose. The phase III trial evaluated 170 confirmed cases of covid-19, 162 of which were observed in the placebo group. There were 10 severe cases, nine of which were in the placebo group. In its announcement, Pfizer said the vaccine could be available to high risk populations in the US by the end of December 2020. Globally, it plans to produce 50m doses in 2020 and up to 1.3bn doses by the end of 2021. The companies have started submission processes in Europe, as well as Australia, Canada, and Japan. The phase III trial began …

Covid-19: Pfizer and BioNTech submit vaccine for US authorisation | The BMJ

Moderna transformed from a hot biotech startup to one of the world's best-known companies as it pursues a coronavirus vaccine.Moderna transformed from a hot biotech startup to one of the world's best-known companies as it pursues a coronavirus vaccine.

How Moderna developed a coronavirus vaccine in record time - Business Insider

Pfizer’s application with the FDA sets in motion a process that could bring limited shots as early as next month.Pfizer’s application with the FDA sets in motion a process that could bring limited shots as early as next month.

search

Pfizer Inc. undefined and BioNTech undefined on Friday submitted an application for an emergency use authorization for their trial COVID-19 vaccine...Pfizer Inc. undefined and BioNTech undefined on Friday submitted an application for an emergency use authorization for their trial COVID-19 vaccine...

Pfizer, BioNTech make it official: COVID-19 vaccine EUA submitted - MarketWatch

Vaccinations in England could start as early as next month providing it receives regulator approval.Vaccinations in England could start as early as next month providing it receives regulator approval.

Covid: Matt Hancock says vaccinations could start in England as early as December | ITV News

American drug-maker Pfizer said Friday it has requested emergency use authorization from the U.S. Food and Drug Administration (FDA) for its COVID-19 vaccine. Pfizer and its German partner BioNTech noted they have also started a similar process with regulatory agencies in Europe. American drug-maker Pfizer said Friday it has requested emergency use authorization from the U.S. Food and Drug Administration (FDA) for its COVID-19 vaccine. Pfizer and its German partner BioNTech noted they have also started a similar process with regulatory agencies in Europe.

COVID-19 Vaccine ‘Help Is on the Way’

Health Secretary Matt Hancock gave an update in a Downing Street press conference Health Secretary Matt Hancock gave an update in a Downing Street press conference

Roll-out of Pfizer Covid-19 vaccine "could start next month" - if approved by safety regulator - Bristol Live

All the latest coronavirus updates from across Hull, East Yorkshire and beyondAll the latest coronavirus updates from across Hull, East Yorkshire and beyond

Lockdown live as UK roll-out of coronavirus vaccine could begin next month - Hull Live

News, analysis and comment from the Financial Times, the worldʼs leading global business publication

Subscribe to read | Financial Times

British health secretary says country ready to start vaccination next month ‘with bulk of the rollout next year’ - Anadolu AgencyBritish health secretary says country ready to start vaccination next month ‘with bulk of the rollout next year’ - Anadolu Agency

UK regulator asked to assess Pfizer vaccine for use

US News: WASHINGTON: US biotech giant Pfizer and German partner BioNTech sought approval Friday to roll out their coronavirus vaccine early, a first step towar.US News: WASHINGTON: US biotech giant Pfizer and German partner BioNTech sought approval Friday to roll out their coronavirus vaccine early, a first step towar.

Covid-19: Pfizer/BioNTech seek first vaccine approval in US - Times of India

The pandemic could end soon for rich countries — but not for developing ones. This is Big Pharma's doingThe pandemic could end soon for rich countries — but not for developing ones. It's the pharmaceutical industry's fault

Big Pharma could supply the whole world with a COVID vaccine. They've chosen not to | Salon.com

Matt Hancock says he is “more and more confident” that life will return to normal in the spring as the NHS plans to give a coronavirus vaccine to every adult who wants one by Easter.The healthMatt Hancock says he is “more and more confident” that life will return to normal in the spring as the NHS plans to give a coronavirus vaccine to every adult who wants one by Easter.The health

Video Icon

Prime Minister Imran Khan authorizes pre-booking of coronavirus vaccinePrime Minister Imran Khan authorizes pre-booking of coronavirus vaccine

Pakistan approves $150m grant to buy COVID-19 vaccine | Pakistan – Gulf News